Potential Molecular Targets for Treating Neuropathic Orofacial Pain Based on Current Findings in Animal Models.

Nagakura, Yukinori et al.·International journal of molecular sciences·2021·Moderate EvidenceReview
RPEP-05636ReviewModerate Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
N=N/A (review)
Participants
N/A (review of PTNP and PTN animal models)

What This Study Found

CGRP receptor antagonists emerge as the most promising molecular target for neuropathic orofacial pain, with sufficient safety and mechanistic data for clinical translation.

Key Numbers

Models: PTNP (nerve trauma) and PTN (root compression); targets: CGRP, inflammation, ectopic discharges, neuron-glia interactions

How They Did This

Narrative review of animal models of post-traumatic trigeminal neuropathic pain (PTNP) and primary trigeminal neuralgia (PTN), and therapeutic candidates identified therein.

Why This Research Matters

Chronic face pain severely affects quality of life and has few effective treatments. Identifying validated molecular targets could lead to new therapies.

What This Study Doesn't Tell Us

Review of animal models. Pain mechanisms in animals may not perfectly represent human neuropathic pain. Clinical translation is not guaranteed.

Trust & Context

Original Title:
Potential Molecular Targets for Treating Neuropathic Orofacial Pain Based on Current Findings in Animal Models.
Published In:
International journal of molecular sciences, 22(12) (2021)
Database ID:
RPEP-05636

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Read More on RethinkPeptides

Cite This Study

RPEP-05636·https://rethinkpeptides.com/research/RPEP-05636

APA

Nagakura, Yukinori; Nagaoka, Shogo; Kurose, Takahiro. (2021). Potential Molecular Targets for Treating Neuropathic Orofacial Pain Based on Current Findings in Animal Models.. International journal of molecular sciences, 22(12). https://doi.org/10.3390/ijms22126406

MLA

Nagakura, Yukinori, et al. "Potential Molecular Targets for Treating Neuropathic Orofacial Pain Based on Current Findings in Animal Models.." International journal of molecular sciences, 2021. https://doi.org/10.3390/ijms22126406

RethinkPeptides

RethinkPeptides Research Database. "Potential Molecular Targets for Treating Neuropathic Orofaci..." RPEP-05636. Retrieved from https://rethinkpeptides.com/research/nagakura-2021-potential-molecular-targets-for

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.